Placebo + tadalafil

Phase 3Completed
0 watching 0 views this week๐Ÿ“ˆ Rising
77
Hype Score

Development Stage

โœ“
Pre-clinical
โœ“
Phase 1
โœ“
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Benign Prostatic Hyperplasia

Conditions

Benign Prostatic Hyperplasia

Trial Timeline

Jan 1, 2009 โ†’ Nov 1, 2009

About Placebo + tadalafil

Placebo + tadalafil is a phase 3 stage product being developed by Eli Lilly for Benign Prostatic Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT00827242. Target conditions include Benign Prostatic Hyperplasia.

Hype Score Breakdown

Clinical
27
Activity
18
Company
10
Novelty
9
Community
10

Clinical Trials (2)

NCT IDPhaseStatus
NCT00833638ApprovedCompleted
NCT00827242Phase 3Completed

Competing Products

20 competing products in Benign Prostatic Hyperplasia

See all competitors